Navigation Links
Gilead Announces Presentation of Positive Phase III Data on,Aztreonam Lysine for Inhalation in Patients With Cystic Fibrosis

SEATTLE--(BUSINESS WIRE)--Apr 19, 2007 - Gilead Sciences, Inc. (Nasdaq:GILD) today announced detailed results of its Phase III AIR-CF2 study evaluating aztreonam lysine for inhalation, an antibiotic, in patients with cystic fibrosis (CF) who have pulmonary Pseudomonas aeruginosa (P. aeruginosa). In the study, a 28-day treatment course of aztreonam lysine significantly improved the time to need for inhaled or intravenous (IV) antibiotics versus placebo. All patients received an initial 28 days of treatment with tobramycin inhalation solution prior to receiving study drug. Aztreonam lysine for inhalation was well tolerated and patients also experienced significant improvements in pulmonary function and respiratory symptoms. The data were presented by Karen S. McCoy, MD, Chief of the Division of Pediatric Pulmonology and Associate Professor of Pediatrics at The Ohio State University College of Medicine and Chief of the Section of Pulmonology at Columbus Children's Hospital, at this year's Cystic Fibrosis Therapeutics Development Network conference in Seattle, Washington. Topline results from this study were previously announced on December 19, 2006.

AIR-CF2 was a randomized, double-blind, placebo-controlled study designed to assess the safety and efficacy of a 28-day treatment course with aztreonam lysine for inhalation following a 28-day treatment course of tobramycin inhalation solution in people with CF who have pulmonary P. aeruginosa. Patients were randomized to receive 28 days of treatment with 75 mg of aztreonam lysine or volume-matched placebo each administered twice (BID) or three times (TID) daily by the eFlow(R) Electronic Nebulizer. Patients were followed for an overall study period of 126 days, with 56 days of observation after receiving aztreonam lysine for inhalation therapy or placebo.

Two hundred and forty-six patients were enrolled in the study and of those 211 were randomized to receive a
'"/>




Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Second Phase III Study Evaluating Gileads Viread for the Treatment of Chronic Hepatitis B Virus Meets Primary Endpoint
2. Second Phase III Study Evaluating Gileads Viread for the Treatment of Chronic Hepatitis B Virus Meets Primary Endpoint
3. Phase III Study Evaluating Gileads Viread for the Treatment of Chronic Hepatitis B Virus Meets Primary Endpoint
4. Gilead Announces Achievement of Primary Efficacy Endpoint in Second Phase III Study of Aztreonam Lysine for Inhalation in Patients With Cystic Fibrosis
5. Gilead Announces Presentation of Long-Term Data for Ambrisentan, a Potential Treatment for Patients With Pulmonary Arterial Hypertension
6. Data from Preclinical Studies of Gilead Nucleotide Compound GS 9219 to be Presented at AACR
7. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
8. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
9. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
10. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
11. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
Post Your Comments:
(Date:4/24/2015)... April 24, 2015  Perrigo Company plc ("Perrigo" or ... of the unsolicited offer from Mylan NV ("Mylan") (NASDAQ: ... shares of Perrigo for $60.00 per share in cash ... share (the "Offer").  The Board previously ... significantly undervalued the Company and its future growth prospects ...
(Date:4/24/2015)... April 24, 2015  New technologies and online ... to educate themselves about products and companies. Likewise, ... techniques available to market researchers seeking insights into ... marketplace, it,s imperative that organizations adjust their consumer ... market opportunities, niches and growth fronts. ...
(Date:4/24/2015)... DUBLIN , Apr. 24, 2015 Research and ... addition of the "Global Biobanking Market 2015-2019" ... the Global Biobanking market to grow at a CAGR ... Global Biobanking market can be divided into two segments: ... and the growth prospects of the Global Biobanking market ...
Breaking Medicine Technology:Perrigo Rejects Mylan Unsolicited Offer 2Perrigo Rejects Mylan Unsolicited Offer 3Perrigo Rejects Mylan Unsolicited Offer 4Pharmaceutical Industry Using New Technologies to Adjust Their Marketing and Research Approaches for Consumers 2Global Biobanking Market Report 2015-2019 - Increase in Strategic Collaborations with Beckman Coulter, Tecan & Thermo Fischer Scientific Dominating 2
... MUNDELEIN, Ill. , July 1 ... and information systems developer, today announces executive changes in ...  John Kershaw, President & CEO, Sysmex America Inc. has ... Secretary; Judy Bosko as Vice President of ...
... SCHAUMBURG, Ill. , July 1 ... today announced that the U.S. Food and Drug Administration ... sodium injection, USP. Heparin is a vital anticoagulant, preventing ... within the blood, routinely used in surgical and dialysis ...
Cached Medicine Technology:Sysmex America Announces Executive Leadership Changes 2FDA Approves Sagent Pharmaceuticals' Heparin Sodium Injection, USP 2FDA Approves Sagent Pharmaceuticals' Heparin Sodium Injection, USP 3FDA Approves Sagent Pharmaceuticals' Heparin Sodium Injection, USP 4
(Date:4/24/2015)... Carvers' goal is to help an ... day in Breck. , Conveniently located in the ... from Breckenridge, this family-owned place since 1995, has ... rentals ( http://www.breckenridgeskishop.com/en/rent-equipment ) and more. , ... in May 2015. With style and function progressing ...
(Date:4/24/2015)... Hollywood, CA (PRWEB) April 24, 2015 ... of sitting down in an interview with ItsNotAboutMe.TV contributor ... Choice Recovery, a holistic treatment center for addiction, of ... awards ceremonies and festivals throughout the year, the EcoLuxe ... top providers of eco-friendly and socially conscious products and ...
(Date:4/24/2015)... April 24, 2015 Anchor Health Administrators ... Field Professionals, today announced their exclusive agreement with LTC ... Term Care Insurance distribution partner. , Anchor has more ... Care Insurance benefits for associations, and is currently the ... Long Term Care Insurance member benefit. , “I ...
(Date:4/24/2015)... Joseph, Missouri (PRWEB) April 24, 2015 ... for veterinarians , UGA is now proud to be ... the care of 16,000 animals a year. This partnership ... care for their animals. , After providing an ... Missouri Veterinary Medical Teaching Hospital (VMTH) wanted to increase ...
(Date:4/24/2015)... 24, 2015 “ Opera ” was featured ... features the latest and coolest technology products available to consumers. ... conducted the review and shared with viewers how this is ... browsers, surfing the internet would not be in existence. But ... the Opera browser is no different. Celebrating their 20th anniversary ...
Breaking Medicine News(10 mins):Health News:Carvers Breckenridge Bike Rentals Offers Demo Mountain, Tandem, Bike Path Cruiser & JR. Bikes in May 2015 2Health News:Karen Salkin Talks with Per Wickstrom at the 2015 EcoLuxe Lounge and the "Salute to the Oscars" Celebration 2Health News:University of Missouri Veterinary Medical Teaching Hospital Teams with UGA 2Health News:A Web Browser That Connects over 350 Million People was Featured on NewsWatch Television 2
... and Safety Advantages Over Current Therapies, MARKHAM, ... data on a novel vitamin D analog, CTA018, ... of Nephrology (ASN) in Philadelphia.,In preclinical models, CTA018 ... replacement therapies, calcitriol and paricalcitol,(Zemplar(R)), the latter currently ...
... Statewide Initiative to,Advance Diabetes Screening for Medicare Beneficiaries, ... Casey Cagle today,applauded the design and implementation of ... it as a model for other cities in,Georgia ... at the Columbus Summit,a meeting hosted by the ...
... Pa., Nov. 6 Spectrum Control, Inc.,(Nasdaq: ... custom electronic,products and systems, announced today that its ... for a microwave integrated assembly used,in military tactical ... with additional orders and releases under the program,expected ...
... Animation,s "Madagascar: Escape 2 Africa(TM)" Happy Meal(TM) Event, ... one minute of fun,each day to help make a difference ... is asking kids and families as it launches One,Minute to ... kids to see what a difference a minute can make. ...
... Web cast live, LAVAL, QC, Nov. 6 /PRNewswire-FirstCall/ ... that on Tuesday, November 11, Mr. Gary,Schmid, President and ... owned subsidiary of BELLUS Health, will present a review ... 10th Annual Healthcare Conference to be held at the ...
... used with no other hormone therapy, is an effective ... 800 women from 65 centers in the United States, ... the study, the first to show that testosterone administered ... postmenopausal women. , Previous studies have shown testosterone ...
Cached Medicine News:Health News:Cytochroma Announces Positive Comparative Data on CTA018 in Chronic Kidney Disease Model 2Health News:Cytochroma Announces Positive Comparative Data on CTA018 in Chronic Kidney Disease Model 3Health News:Cytochroma Announces Positive Comparative Data on CTA018 in Chronic Kidney Disease Model 4Health News:Cytochroma Announces Positive Comparative Data on CTA018 in Chronic Kidney Disease Model 5Health News:Columbus Medicare Diabetes Screening Project Cited as Model for State by Lt. Governor Casey Cagle 2Health News:Columbus Medicare Diabetes Screening Project Cited as Model for State by Lt. Governor Casey Cagle 3Health News:Spectrum Control Receives $1.2 Million Order for Microwave Integrated Assemblies 2Health News:McDonald's(R) Encourages Kids to Take One Minute to Move It 2Health News:McDonald's(R) Encourages Kids to Take One Minute to Move It 3Health News:McDonald's(R) Encourages Kids to Take One Minute to Move It 4Health News:BELLUS Health to present at the Rodman and Renshaw 10th Annual Healthcare Conference 2
The rubber, whistle tip catheter with thumb valve has two side eyes to help minimize trauma....
Gentle-Flo® Vactrol® Connector., ,Indications For Usage: ,Removal of secretions from respiratory tract....
... 8 Suction Catheters With Contro-Vac Valve and ... Low-Risk Respiratory Suctioning, ,Medline's 6 and ... DeLee Tips are the optimal tools for ... a forward placed suction valve to minimize ...
... available in two tip styles- ... with staggered eyes, and the ... of catheter valve options, SAFE-T-VAC ... control with virtually no residual ...
Medicine Products: